Researchers have identified that cancer immunotherapy can lead to colitis due to the activation of the immune system. Certain immunotherapies, such as immune checkpoint inhibitors, boost the immune response against cancer cells but may also inadvertently target healthy cells, including those in the colon. This immune system activation can cause inflammation in the colon, resulting in colitis. Understanding the underlying mechanisms is crucial for improving the safety and efficacy of cancer immunotherapy and managing potential side effects like colitis.
Related Posts
Is ectopic thyroid tissue cancerous?
Ectopic thyroid cancer (ETC) is primary thyroid cancer occurring in ectopic thyroid tissue, and its incidence rate is approximately 0.3%–0.5% of thyroid cancer. Only approximately 132 cases of ETC have been diagnosed and treated worldwide in the past 110 years, with most of them being adults. What is the treatment for ectopic thyroid tissue? Patients […]
Beyond Green: The Kaleidoscope of BoPQL2 Genetics!
Scientists focused on the ornamental trait of leaf color in ornamental kale, a significant feature of its aesthetic appeal. They identified the BoPQL2 gene as differentially expressed between white and green leaf tissues in ornamental kale. By cloning the BoPQL2 gene from two different kale varieties with distinct leaf colors, they discovered five SNPs, leading […]
Assessing Catellicoccus marimammalium for Evaluating Gull-Related Fecal Contamination in Lake Erie Beach Waters
Lake Erie’s recreational beaches face persistent fecal contamination, impacting water quality and public health. Villa Angela and Headlands beaches in Ohio attract numerous visitors but encounter advisories due to high fecal indicator levels, primarily from gull droppings. Traditional methods assessing gull-related contamination, like gull counts or droppings, prove inadequate due to gulls’ dynamic behavior and […]